Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Thromboembolism/epidemiology"'
Autor:
Wiegers, Hanke M. G., Körmendiné Farkas, D. ra, Horváth-Puhó, Erzsébet, Middeldorp, Saskia, van Es, Nick, Sørensen, Henrik T.
Publikováno v:
Lancet Haematology, 10, 5, pp. e359-e366
Lancet Haematology, 10, e359-e366
Wiegers, H M G, Körmendiné Farkas, D, Horváth-Puhó, E, Middeldorp, S, van Es, N & Sørensen, H T 2023, ' Incidence and prognosis of superficial vein thrombosis during pregnancy and the post-partum period : a Danish nationwide cohort study ', Lancet Haematol, vol. 10, no. 5, pp. e359-e366 . https://doi.org/10.1016/S2352-3026(23)00013-3
The Lancet Haematology. Lancet Publishing Group
Lancet Haematology, 10, e359-e366
Wiegers, H M G, Körmendiné Farkas, D, Horváth-Puhó, E, Middeldorp, S, van Es, N & Sørensen, H T 2023, ' Incidence and prognosis of superficial vein thrombosis during pregnancy and the post-partum period : a Danish nationwide cohort study ', Lancet Haematol, vol. 10, no. 5, pp. e359-e366 . https://doi.org/10.1016/S2352-3026(23)00013-3
The Lancet Haematology. Lancet Publishing Group
Item does not contain fulltext BACKGROUND: The incidence of superficial vein thrombosis (SVT) of the legs and the subsequent risk of venous thromboembolism during pregnancy and the post-partum period is unknown. To better understand the clinical cour
Autor:
Kasper Bonnesen, Frederikus A. Klok, Mads J. Andersen, Asger Andersen, Jens E. Nielsen-Kudsk, Søren Mellemkjær, Henrik T. Sørensen, Morten Schmidt
Publikováno v:
Bonnesen, K, Klok, F A, Andersen, M J, Andersen, A, Nielsen-Kudsk, J E, Mellemkjær, S, Sørensen, H T & Schmidt, M 2023, ' Long-Term Prognostic Impact of Pulmonary Hypertension After Venous Thromboembolism ', The American Journal of Cardiology, vol. 199, pp. 92-99 . https://doi.org/10.1016/j.amjcard.2023.04.023
Pulmonary embolism is a risk factor for chronic thromboembolic pulmonary hypertension (CTEPH), but the prognostic impact of CTEPH on venous thromboembolism (VTE) mortality remains unclear. We examined the impact of CTEPH and other pulmonary hypertens
Autor:
Ivana Jurin, Marko Lucijanić, Nevenka Piskač Živković, Kristina Lalić, Anamarija Zrilić Vrkljan, Linda Malnar Janeš, Ivona Kovačević, Tomislav Čikara, Anica Sabljić, Nikolina Bušić, Gorana Vukorepa, Irzal Hadžibegović, Ivica Lukšić, Bruno Baršić
Publikováno v:
Croatian Medical Journal
Volume 63
Issue 1
Volume 63
Issue 1
Aim To evaluate the burden and predictors of throm - boembolic complications in a large real-life cohort of hos - pitalized patients with established coronavirus disease 2019 (COVID-19). Methods We retrospectively reviewed the records of 4014 consecu
Publikováno v:
Farrell, J, Docherty, A B, Thorpe, M G, Shaw, K, Harrison, E M & Lone, N I 2022, ' Twelve-month risk of thromboembolic events in COVID-19 hospital survivors in Scotland ', Anaesthesia: Peri-operative medicine, critical care and pain, vol. 77, no. 12, pp. 1445-1447 . https://doi.org/10.1111/anae.15826
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2acdb9e8d961127f1ec1c9f18d879811
https://www.pure.ed.ac.uk/ws/files/296206367/Anaesthesia_2022_Farrell_Twelve_month_risk_of_thromboembolic_events_in_COVID_19_hospital_survivors_in_Scotland.pdf
https://www.pure.ed.ac.uk/ws/files/296206367/Anaesthesia_2022_Farrell_Twelve_month_risk_of_thromboembolic_events_in_COVID_19_hospital_survivors_in_Scotland.pdf
Autor:
Lip, Gregory Y. H., Murphy, Richard R., Sahiar, Farhad, Ingall, Timothy J., Dhamane, Amol D., Ferri, Mauricio, Hlavacek, Patrick, Preib, Madison T., Keshishian, Allison, Russ, Cristina, Rosenblatt, Lisa, Yuce, Huseyin, Deitelzweig, Steven
Publikováno v:
Lip, G Y H, Murphy, R R, Sahiar, F, Ingall, T J, Dhamane, A D, Ferri, M, Hlavacek, P, Preib, M T, Keshishian, A, Russ, C, Rosenblatt, L, Yuce, H & Deitelzweig, S 2022, ' Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants ', JAMA Network Open, vol. 5, no. 8, e2229333, pp. e2229333 . https://doi.org/10.1001/jamanetworkopen.2022.29333
Importance: The CHA2DS2-VASc score (calculated as congestive heart failure, hypertension, age 75 years and older, diabetes, stroke or TIA, vascular disease, age 65 to 74 years, and sex category) is the standard for assessing risk of stroke and system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f4e946df38e270e0fdb2535041390f
https://vbn.aau.dk/da/publications/99dcd0d8-babf-4bc4-a6e0-0fdaf5906f05
https://vbn.aau.dk/da/publications/99dcd0d8-babf-4bc4-a6e0-0fdaf5906f05
Autor:
Betensky, M., Kulkarni, K., Rizzi, M., Jones, S., Brandão, L.R., Faustino, EVS, Goldenberg, N.A., Sharathkumar, A.
Publikováno v:
Journal of thrombosis and haemostasis, vol. 20, no. 7, pp. 1729-1734
Clinically unsuspected venous thromboembolism (VTE) in children is defined as a VTE diagnosed via imaging test performed for surveillance (i.e., with an intent to identify clinically silent VTEs) or incidentally found (most often via imaging performe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::749a12210b362f5deda12516b3a7a890
https://serval.unil.ch/resource/serval:BIB_2C285649DEC4.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_2C285649DEC4.P001/REF.pdf
Autor:
Nikoletta A Theochari, Stefanos Giannopoulos, Christina A. Theochari, Damianos G. Kokkinidis, Styliani Mantziari, Dimitrios Schizas, Orestis Lyros, Aristotelis Kechagias
Publikováno v:
Surgery today, vol. 52, no. 2, pp. 171-181
Although esophagectomy remains the preferred treatment for esophageal cancer, it is still associated with a number of complications, including post-operative venous thromboembolism (VTE). The aim of this study was to summarize the reported incidence
Autor:
Reimar W. Thomsen, Torben Larsen, Ole S. Søgaard, Simone Bastrup Israelsen, Lene Fogt Lundbo, Michael Dalager-Pedersen, Lars Haukali Omland, Henrik Nielsen, Nanna B. Johansen, Jacob Bodilsen, Theis Mariager, Lars Christian Lund, Maja Hellfritzsch, Rannva Winther, Anton Pottegård, Stig Lønberg Nielsen, Zitta Barrella Harboe
Publikováno v:
Dalager-Pedersen, M, Lund, L C, Mariager, T, Winther, R, Hellfritzsch, M, Larsen, T B, Thomsen, R W, Johansen, N B, Søgaard, O S, Nielsen, S L, Omland, L, Lundbo, L F, Israelsen, S B, Harboe, Z B, Pottegård, A, Nielsen, H & Bodilsen, J 2021, ' Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19) : A Nationwide, Population-Based Cohort Study ', Clinical Infectious Diseases, vol. 73, no. 12, pp. 2283–2293 . https://doi.org/10.1093/cid/ciab003
Clinical Infectious Diseases
Dalager-Pedersen, M, Lund, L C, Mariager, T, Winther, R, Hellfritzsch, M, Larsen, T B, Thomsen, R W, Johansen, N B, Søgaard, O S, Nielsen, S L, Omland, L H, Lundbo, L F, Israelsen, S B, Harboe, Z B, Pottegård, A, Nielsen, H & Bodilsen, J 2021, ' Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19) : A Nationwide, Population-Based Cohort Study ', Clinical Infectious Diseases, vol. 73, no. 12, pp. 2283-2293 . https://doi.org/10.1093/cid/ciab003
Dalager-Pedersen, M, Lund, L C, Mariager, T, Winther, R, Poulsen, M H, Larsen, T B, Thomsen, R W, Johansen, N B, Søgaard, O S, Nielsen, S L, Omland, L H H, Lundbo, L F, Israelsen, S B, Harboe, Z B, Pottegård, A, Nielsen, H & Bodilsen, J 2021, ' Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19) : A nationwide population-based cohort study ', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 73, no. 12, pp. 2283-2293 . https://doi.org/10.1093/cid/ciab003
Clinical Infectious Diseases
Dalager-Pedersen, M, Lund, L C, Mariager, T, Winther, R, Hellfritzsch, M, Larsen, T B, Thomsen, R W, Johansen, N B, Søgaard, O S, Nielsen, S L, Omland, L H, Lundbo, L F, Israelsen, S B, Harboe, Z B, Pottegård, A, Nielsen, H & Bodilsen, J 2021, ' Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19) : A Nationwide, Population-Based Cohort Study ', Clinical Infectious Diseases, vol. 73, no. 12, pp. 2283-2293 . https://doi.org/10.1093/cid/ciab003
Dalager-Pedersen, M, Lund, L C, Mariager, T, Winther, R, Poulsen, M H, Larsen, T B, Thomsen, R W, Johansen, N B, Søgaard, O S, Nielsen, S L, Omland, L H H, Lundbo, L F, Israelsen, S B, Harboe, Z B, Pottegård, A, Nielsen, H & Bodilsen, J 2021, ' Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19) : A nationwide population-based cohort study ', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 73, no. 12, pp. 2283-2293 . https://doi.org/10.1093/cid/ciab003
Background Venous thromboembolism (VTE) is a potentially fatal complication of SARS-CoV-2 infection and thromboprophylaxis should be balanced against risk of bleeding. This study aimed to examine risks of VTE and major bleeding in hospitalized and co
Autor:
Mette Søgaard, Flemming Skjøth, Peter B. Nielsen, Jesper Smit, Michael Dalager-Pedersen, Torben B. Larsen, Gregory Y. H. Lip
Publikováno v:
Søgaard, M, Skjøth, F, Nielsen, P B, Smit, J, Dalager-Pedersen, M, Larsen, T B & Lip, G Y H 2022, ' Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy ', JAMA NETWORK OPEN, vol. 5, no. 5, e2213945, pp. E2213945 . https://doi.org/10.1001/jamanetworkopen.2022.13945
Importance: New-onset atrial fibrillation (AF) is commonly reported in patients with severe infections. However, the absolute risk of thromboembolic events without anticoagulation remains unknown.Objective: To investigate the thromboembolic risks ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4765db516b5885b740356d3b16340107
https://vbn.aau.dk/da/publications/61bd744e-6b0e-4b7b-8490-497347ca0aab
https://vbn.aau.dk/da/publications/61bd744e-6b0e-4b7b-8490-497347ca0aab
Autor:
Rodolfo J. Dennis, Jairo H. Roa, Juan Villadiego, Freddy Méndez, Elías Vieda, Héctor Restrepo
Publikováno v:
Biomédica: revista del Instituto Nacional de Salud, Vol 31, Iss 2, Pp 200-8 (2011)
Introducción. La profilaxis en pacientes de tratamiento médico o quirúrgico con riesgo de tromboembolia venosa, requiere ser evaluada para obtener suficiente información que contribuya a mejorar estas prácticas, para que sean efectivas y eficace
Externí odkaz:
https://doaj.org/article/ae6200e770584e168e1b556026c681eb